Search - tctmd.com

Displaying 301 - 320 of 510

Sort: Relevancy | Date

News Features

Las Aprobaciones de los Balones Recubiertos de Fármacos ‘Cambiarán’ el Tratamiento de la EAP

L.A. McKeown

January 28, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

News Daily News

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Salynn Boyles

December 11, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Todd Neale

November 17, 2014

Presentation AHA 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presenter: Dean J. Kereiakes

November 16, 2014

News Conference News AHA 2014

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

Long-Term Better than Short-Term Prasugrel After PES Stenting

November 15, 2014

News Conference News AHA 2014

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Yael L. Maxwell

November 15, 2014

News Daily News

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

Caitlin E. Cox

October 24, 2014

News Daily News

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

Caitlin E. Cox

October 24, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Presentation

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Presenter: Monika Herten

October 16, 2014

Presentation TCT 2014

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq

September 16, 2014

Presentation TCT 2014

Short- and long-term safety evaluation of a novel bioresorbable scaffold in a miniature swine coronary artery model

Presenter: Kazuyuki Yahagi

September 16, 2014

Presentation TCT 2014

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Presenter: Rafael Ruiz-Salmeron

September 16, 2014

Advertisement

Las Aprobaciones de los Balones Recubiertos de Fármacos ‘Cambiarán’ el Tratamiento de la EAP

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

DES With Biodegradable Polymer Safe, Durable Through 5 Years

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Long-Term Better than Short-Term Prasugrel After PES Stenting

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

Short- and long-term safety evaluation of a novel bioresorbable scaffold in a miniature swine coronary artery model

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content